Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-21

Clinical Trial Update: Topical Timolol for Superficial Infantile Hemangioma [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating topical timolol for superficial infantile hemangioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Timolol (timolol)

Snippet

Sponsor: Mahidol University | Conditions: Hemangioma | Phase 3 | Status: COMPLETED